Rate My Professor Simone Schoenwaelder

Schoenwaelder's academic interests center on platelet biology, including activation, aggregation, signal transduction, hemostasis, thrombosis, apoptosis, and cell signaling, with particular emphasis on atherothrombosis and novel anticoagulant development for stroke prevention and treatment. She has authored over 110 publications, accumulating more than 7,460 citations. Key contributions include 'Intrinsic apoptosis circumvents the functional decline of circulating platelets, but does not cause the storage lesion' (2018), 'Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets' (2018), 'Neutrophil macroaggregates promote widespread pulmonary thrombosis after gut ischemia' (2017, JCI Insight), 'Endogenous fibrinolysis facilitates clot retraction in vivo' (2017), and '14-3-3ζ regulates the mitochondrial respiratory reserve linked to platelet phosphatidylserine exposure and procoagulant function' (2016). Her research has garnered major awards and funding, such as the NHMRC Project Grant of $750,000 in 2020 for developing safer anticoagulants for stroke treatment, the Brain Foundation Research Gift in 2019, and NSW Cardiovascular Research Capacity Building Grants. Associated with Shaun P. Jackson's Lab, her work influences antithrombotic therapies, including tick-derived compounds advancing to clinical trials. She has delivered public lectures, including at the University of Sydney Women's College, and currently heads Biology at Thrombio Pty Ltd.